Medicine and Dentistry
Beta Adrenergic Receptor Blocking Agent
100%
Combination Therapy
100%
Calcium Channel Blocking Agent
100%
Stable Angina Pectoris
100%
Stable Angina
100%
Blood Pressure
50%
Nifedipine
33%
Verapamil
33%
Heart Left Ventricle Failure
16%
Patient Selection
16%
Drug Therapy
16%
Heart Performance
16%
Heart Left Ventricle Function
16%
Atrioventricular Node
16%
Heart Muscle Oxygen Consumption
16%
Drug Interaction
16%
Heart Ventricle Conduction
16%
Clinical Trial
16%
Clinician
16%
Hemodynamic
16%
Diltiazem
16%
Diseases
16%
Keyphrases
Combination Therapy
100%
Calcium Channel Blockers
100%
Beta-blockers
100%
Angina Pectoris
100%
Heart Rate
33%
Blood Pressure
33%
Cardiac Effects
22%
Nifedipine
22%
Verapamil
22%
Therapeutic Efficacy
11%
Heart Blood
11%
Clinical Monitoring
11%
Drug Interactions
11%
Electrophysiologic
11%
Conduction System Disease
11%
Right Heart
11%
Left Ventricular Dysfunction
11%
Performance Variables
11%
Drug Treatment
11%
Patient Selection
11%
Cardio-depressant
11%
Cardiac Performance
11%
Pharmacologic Management
11%
Drug Class
11%
Short-term Administration
11%
Double-blind Clinical Trial
11%
Ventricular Conduction
11%
Pressure Rate
11%
During Exercise
11%
Left Heart
11%
Filling Pressure
11%
Myocardial Oxygen Consumption
11%
Atrioventricular Node
11%
Diltiazem
11%
Symptom Benefit
11%
Preserved Left Ventricular Function
11%
Chronic Stable Angina
11%
Pharmacology, Toxicology and Pharmaceutical Science
Beta Adrenergic Receptor Blocking Agent
100%
Calcium Channel Blocker
100%
Stable Angina Pectoris
100%
Combination Therapy
100%
Nifedipine
33%
Verapamil
33%
Diltiazem
16%
Clinical Trial
16%
Pharmacotherapy
16%
Heart Left Ventricle Failure
16%
Drug Interaction
16%
Diseases
16%